ALNYLAM PHARMACEUTICALS, INC.
Pharmaceutical Preparations | SIC: 2834Phone: (617) 551-8200
EIN: 770602661
State Location: MA
- Nasdaq:ALNY
Form: SCHEDULE 13G/A
Filing Date: 06 May 2026Report Date:
Accepted: 06 May 2026 09:00 a.m.
Accession Number: 0000315066-26-001107
File Number: 005-79884
Film Number: 26946559
Documents
Primary Document
Accepted: 06 May 2026 09:00 a.m.
0000315066-26-001107-index-headers.html
Last Modified: 06 May 2026 09:00 a.m.
0000315066-26-001107-index.html
Last Modified: 06 May 2026 09:00 a.m.
0000315066-26-001107.txt
Last Modified: 06 May 2026 09:00 a.m.
exhibit99.txt
Last Modified: 06 May 2026 09:00 a.m.
primary_doc.xml
Last Modified: 06 May 2026 09:00 a.m.